文献速递糖尿病

美国墨西哥裔老年人群的糖尿病筛查与监测

Diabetes Screening and Monitoring Among Older Mexican-Origin Populations in the U.S.
PubMed 文献 · Diabetes Care · 2022-01-01

该回顾性观察研究比较拉丁裔与非拉丁裔白人糖尿病患者的糖化血红蛋白监测率及非糖尿病者的筛查 odds,并分析社区墨西哥裔比例的影响。结果显示拉丁裔患者监测率更高(aRR 1.18),非糖尿病拉丁裔筛查 odds 更高(aOR 1.25),但仅低墨西哥裔比例社区的拉丁裔监测率升高(aRR 1.31)。

要点

  • 拉丁裔糖尿病患者 HbA1c 监测率比非拉丁裔白人高 18%(aRR 1.18)。
  • 无糖尿病拉丁裔的 HbA1c 筛查 odds 比非拉丁裔白人高 25%(aOR 1.25)。
  • 仅低墨西哥裔比例社区的拉丁裔监测率升高(aRR 1.31)。

核心结论

  • 研究发现拉丁裔亚群社区特征相关的医疗利用差异,可为日益多样化的拉丁裔患者群体的糖尿病照护提供参考。
  • 作者认为关注糖尿病照护的临床医生和研究者应采取措施改善糖尿病公平性并预防治疗中的不公平。

研究设计与样本

  • 回顾性观察研究,链接美国社区调查获得的社区层面拉丁裔亚群数据。
  • 使用广义估计方程负二项回归和 logistic 回归模型,调整患者层面协变量。
  • 比较糖尿病患者年度 HbA1c 监测率及非糖尿病患者 HbA1c 筛查 odds,按族裔及社区墨西哥裔人口比例分层(低 0.0-22.0%、中 22.0-55.7%、高 55.7-98.0%)。

主要发现

  • 拉丁裔糖尿病患者 HbA1c 检测率比非拉丁裔白人糖尿病患者高 18%(aRR 1.18 [95% CI 1.07-1.29])。
  • 无糖尿病拉丁裔的筛查 odds 比无糖尿病非拉丁裔白人高 25%(aOR 1.25 [95% CI 1.15-1.36])。
  • 以社区墨西哥裔人口比例为主要自变量时,所有无糖尿病拉丁裔的 HbA1c 筛查 odds 均高于非拉丁裔白人,但仅低墨西哥裔比例社区的拉丁裔监测率升高(aRR 1.31 [95% CI 1.15-1.49])。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of the study is to examine diabetes screening and monitoring among Latino individuals as compared with non-Latino White individuals and to better understand how we can use neighborhood data to address diabetes care inequities. RESEARCH DESIGN AND METHODS: This is a retrospective observational study linked with neighborhood-level Latino subgroup data obtained from the American Community Survey. We used generalized estimating equation negative binomial and logistic regression models adjusted for patient-level covariates to compare annual rates of glycated hemoglobin (HbA1c) monitoring for those with diabetes and odds of HbA1c screening for those without diabetes by ethnicity and among Latinos living in neighborhoods with low (0.0-22.0%), medium (22.0-55.7%), and high (55.7-98.0%) population percent of Mexican origin. RESULTS: Latino individuals with diabetes had 18% higher rates of HbA1c testing than non-Latino White individuals with diabetes (adjusted rate ratio [aRR] 1.18 [95% CI 1.07-1.29]), and Latinos without diabetes had 25% higher odds of screening (adjusted odds ratio 1.25 [95% CI 1.15-1.36]) than non-Latino White individuals without diabetes. In the analyses in which neighborhood-level percent Mexican population was the main independent variable, all Latinos without diabetes had higher odds of HbA1c screening compared with non-Latino White individuals, yet only those living in low percent Mexican-origin neighborhoods had increased monitoring rates (aRR 1.31 [95% CI 1.15-1.49]). CONCLUSIONS: These findings reveal novel variation in health care utilization according to Latino subgroup neighborhood characteristics and could inform the delivery of diabetes care for a growing and increasingly diverse Latino patient population. Clinicians and researchers whose work focuses on diabetes care should take steps to improve equity in diabetes and prevent inequity in treatment.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Datta R, Lucas JA, Marino M, et al. Diabetes Screening and Monitoring Among Older Mexican-Origin Populations in the U.S. Diabetes Care. 2022. PMID: 35587616. doi:10.2337/dc21-2483

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。